FUJIFILM Biosciences Cell & Gene Tech Expo April 2026: Cell Therapy

This presentation explores how raw material selection, media composition and process design decisions shape the robustness and scalability of cell therapy manufacturing. Our speaker Goncalo Regalo, Sr Product Manager for Cell Therapy for FUJIFILM Biosciences, will discuss strategies for managing variability and designing processes that translate effectively form research to clinical production.

By attending this session, participants will be able to:

• Identify how early raw material and media formulation decisions influence critical quality attributes and process robustness
• Understand how raw material qualification strategies evolve from early development through clinical and commercial manufacturing
• Evaluate approaches for managing variability in patient-derived starting material
• Assess scalable and modular process design strategies for cell therapy manufacturing

About FUJIFILM Biosciences

FUJIFILM Biosciences is a global supplier to the life sciences market with a foundation in cell culture dating back to 1970, offering products and services that support healthcare advancement. Its expanding portfolio serves life science research, cell and gene therapy, and large-scale production of biotherapeutics and vaccines, earning the trust of researchers and manufacturers worldwide. For over 50 years, the company has focused on delivering high-quality, responsive products and custom solutions to help bring innovative and accessible therapies to patients. Operating under strict ISO, FDA, and cGMP standards across facilities in the United States, Japan, the Netherlands, and China, it is a subsidiary of FUJIFILM Holdings Corporation and aligns with the FUJIFILM Sustainability Value Plan 2030.